The role of tristetraprolin in control of breast cancer progression
三四脯氨酸在控制乳腺癌进展中的作用
基本信息
- 批准号:8221172
- 负责人:
- 金额:$ 31.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-08 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAdenineArthritisAutoimmunityBindingBreast Cancer TreatmentCellsCpG IslandsDataDendritic CellsElementsGene TargetingGoalsGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorHomeostasisHumanHyperplasiaImmunologicsInflammationInflammatory ResponseInterleukin-24InterleukinsKnockout MiceLipidsMaintenanceMammary Gland ParenchymaMammary NeoplasmsMammary glandMediatingMessenger RNAMethylationModelingMolecularMusMyelogenousNeoplasm MetastasisPatientsPlayProstaglandin-Endoperoxide SynthaseProteinsRegulationRoleSignal PathwayTIS11 proteinTNF geneTherapeuticTherapeutic EffectTimeTumor Necrosis Factor-alphaUridineZinc Fingerschemokinecytokineinterleukin-23mRNA Decaymacrophagemalignant breast neoplasmmembermouse modelneoplastic cellnew therapeutic targetnoveloverexpressionreconstitutiontranscription factortumortumor growthtumor progression
项目摘要
DESCRIPTION (provided by applicant): Expression of tumor-promoting factors such as cytokines and lipid molecules from tumor cells play critical roles in tumor growth and metastasis. However, the mechanisms by which tumor cells produce these factors are still largely unknown. Recently, we have found that the expression of tristetraprolin (TTP), a zinc finger protein promoting mRNA decay of many target genes, is markedly reduced in breast tumors and tumor cells. More importantly, TTP deficient mice show increased metastases and reduced survival in a mouse mammary gland tumor model. Therefore, we hypothesize that the impaired TTP expression in breast tumor cells promotes tumor metastases via enhancing expression of tumor-promoting factors. TTP may serve as a novel therapeutic target for breast cancer treatment. TTP is a member of CCCH tandem zinc finger proteins and involved in the regulation of inflammatory responses at the post-transcriptional level. TTP binds to adenine-uridine-rich elements (AREs) within the 3' untranslated region (3'UTR) causing destabilization of mRNAs encoding TNF-1, GM-CSF, et al. Overproduction of the proinflammatory cytokines in TTP knockout mice results in a severe systemic inflammatory response including arthritis, autoimmunity and myeloid hyperplasia. Collectively, all evidence indicates that TTP is a critical protein involved in the control of inflammation and maintenance of homeostasis. We recently found that the reduced TTP expression in breast tumors was correlated with increased Th17 cells and enhanced IL-23 expression in the tumor microenvironment. IL-23 has been shown to play an important role in tumor progression by promoting tumor growth and metastasis. Our data indicate for the first time that breast tumor cells could behave like macrophage and DCs to secrete IL-23. In addition, over- expression of TTP in breast tumor cells suppressed IL-23 expression. Since the molecular mechanisms of the enhanced IL-23 and reduced TTP expression in breast tumor cells are largely unknown, in this study, we propose to: (1) Investigate the molecular mechanisms and signaling pathways by which TTP inhibits IL-23 expression in breast tumor cells; (2) Identify the molecular mechanisms that regulate TTP expression in breast tumor cells; (3) Evaluate the therapeutic effects of targeting IL-23 and TTP expression in tumor cells on breast tumor growth and metastasis. Our long-term goal is to elucidate the cellular, molecular and immunologic mechanisms by which TTP suppresses breast tumor progression, and ultimately to develop therapeutic approaches that could reconstitute TTP expression in breast tumors in a tumor-specific manner as a novel breast cancer treatment.
PUBLIC HEALTH RELEVANCE: Expression of tumor-promoting factors by tumor cells play critical roles for tumor growth and metastasis. We hypothesize that the impaired tristetraprolin (TTP) expression in breast tumor cells promotes tumor metastasis via enhancing expression of tumor-promoting factors. Our goal is to elucidate the cellular, molecular and immunologic mechanisms by which TTP suppresses breast tumor progression, and ultimately to develop therapeutic approaches that could reconstitute TTP expression in breast tumors in a tumor-specific manner as a novel breast cancer treatment.
描述(由申请人提供):肿瘤细胞中促肿瘤因子(如细胞因子和脂质分子)的表达在肿瘤生长和转移中起关键作用。然而,肿瘤细胞产生这些因子的机制在很大程度上仍然是未知的。最近,我们已经发现,表达tristetraprolin(TTP),锌指蛋白促进许多靶基因的mRNA衰变,是显着减少乳腺肿瘤和肿瘤细胞。更重要的是,TTP缺陷型小鼠在小鼠乳腺肿瘤模型中显示转移增加和存活减少。因此,我们推测乳腺肿瘤细胞中受损的TTP表达通过增强肿瘤促进因子的表达来促进肿瘤转移。TTP可能成为乳腺癌治疗的新靶点。TTP是CCCH串联锌指蛋白的成员,在转录后水平参与炎症反应的调节。TTP与3'非翻译区(3' UTR)内的腺嘌呤-尿苷富集元件(战神)结合,导致编码TNF-1、GM-CSF等的mRNA的不稳定。在TTP敲除小鼠中,促炎细胞因子的过度产生导致严重的全身炎症反应,包括关节炎、自身免疫和骨髓增生。总的来说,所有的证据表明,TTP是一个关键的蛋白质参与控制炎症和维持稳态。我们最近发现,乳腺肿瘤中TTP表达的降低与肿瘤微环境中Th 17细胞的增加和IL-23表达的增强相关。IL-23通过促进肿瘤生长和转移在肿瘤进展中发挥重要作用。我们的数据首次表明乳腺肿瘤细胞可以像巨噬细胞和DC一样分泌IL-23。此外,TTP在乳腺肿瘤细胞中的过表达抑制了IL-23的表达.由于乳腺癌细胞中IL-23表达增强和TTP表达降低的分子机制尚不清楚,因此本研究拟:(1)探讨TTP抑制乳腺癌细胞IL-23表达的分子机制和信号通路;(2)确定调节乳腺癌细胞中TTP表达的分子机制;(3)评价靶向IL-23和TTP在肿瘤细胞中表达对乳腺肿瘤生长和转移的治疗作用。我们的长期目标是阐明TTP抑制乳腺肿瘤进展的细胞、分子和免疫学机制,并最终开发出能够以肿瘤特异性方式重建乳腺肿瘤中TTP表达的治疗方法,作为一种新的乳腺癌治疗方法。
公共卫生相关性: 肿瘤细胞表达肿瘤促进因子对肿瘤的生长和转移起关键作用。我们推测乳腺肿瘤细胞中受损的tristetraprolin(TTP)表达通过增强肿瘤促进因子的表达来促进肿瘤转移。我们的目标是阐明TTP抑制乳腺肿瘤进展的细胞、分子和免疫学机制,并最终开发出能够以肿瘤特异性方式重建乳腺肿瘤中TTP表达的治疗方法,作为一种新的乳腺癌治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jianguo Liu其他文献
Jianguo Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jianguo Liu', 18)}}的其他基金
Role of RNA-binding protein in immune evasion of Mtb in macrophages
RNA结合蛋白在巨噬细胞中Mtb免疫逃避中的作用
- 批准号:
10634764 - 财政年份:2022
- 资助金额:
$ 31.13万 - 项目类别:
Role of RNA-binding protein in immune evasion of Mtb in macrophages
RNA结合蛋白在巨噬细胞中Mtb免疫逃避中的作用
- 批准号:
10511464 - 财政年份:2022
- 资助金额:
$ 31.13万 - 项目类别:
Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer
MALT1抑制剂对内分泌耐药乳腺癌的临床前测试
- 批准号:
10579334 - 财政年份:2022
- 资助金额:
$ 31.13万 - 项目类别:
Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer
MALT1抑制剂对内分泌耐药乳腺癌的临床前测试
- 批准号:
10435975 - 财政年份:2022
- 资助金额:
$ 31.13万 - 项目类别:
A new target for host-directed therapy against TB infection
针对结核感染的宿主定向治疗的新靶点
- 批准号:
10256733 - 财政年份:2020
- 资助金额:
$ 31.13万 - 项目类别:
A new target for host-directed therapy against TB infection
针对结核感染的宿主定向治疗的新靶点
- 批准号:
10057563 - 财政年份:2020
- 资助金额:
$ 31.13万 - 项目类别:
Mechanisms of IL28B genetic variation-mediated clearance of hepatitis C virus
IL28B基因变异介导的丙型肝炎病毒清除机制
- 批准号:
8445769 - 财政年份:2013
- 资助金额:
$ 31.13万 - 项目类别:
Mechanisms of IL28B genetic variation-mediated clearance of hepatitis C virus
IL28B基因变异介导的丙型肝炎病毒清除机制
- 批准号:
8732600 - 财政年份:2013
- 资助金额:
$ 31.13万 - 项目类别:
The role of tristetraprolin in control of breast cancer progression
三四脯氨酸在控制乳腺癌进展中的作用
- 批准号:
9079413 - 财政年份:2012
- 资助金额:
$ 31.13万 - 项目类别:
The role of tristetraprolin in control of breast cancer progression
三四脯氨酸在控制乳腺癌进展中的作用
- 批准号:
8860146 - 财政年份:2012
- 资助金额:
$ 31.13万 - 项目类别:
相似海外基金
Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
- 批准号:
573541-2022 - 财政年份:2022
- 资助金额:
$ 31.13万 - 项目类别:
University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
- 批准号:
2744317 - 财政年份:2022
- 资助金额:
$ 31.13万 - 项目类别:
Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
- 批准号:
MR/V010948/1 - 财政年份:2021
- 资助金额:
$ 31.13万 - 项目类别:
Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10019570 - 财政年份:2019
- 资助金额:
$ 31.13万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10223370 - 财政年份:2019
- 资助金额:
$ 31.13万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10455108 - 财政年份:2019
- 资助金额:
$ 31.13万 - 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
- 批准号:
255762 - 财政年份:2012
- 资助金额:
$ 31.13万 - 项目类别:
Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
- 批准号:
20790351 - 财政年份:2008
- 资助金额:
$ 31.13万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
- 批准号:
19370021 - 财政年份:2007
- 资助金额:
$ 31.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
- 批准号:
7131841 - 财政年份:2006
- 资助金额:
$ 31.13万 - 项目类别: